Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Follow-Up Questions
What is Avantor Inc (AVTR)'s P/E Ratio?
The P/E ratio of Avantor Inc is 13.2946
Who is the CEO of Avantor Inc?
Mr. Emmanuel Ligner is the President of Avantor Inc, joining the firm since 2025.
What is the price performance of AVTR stock?
The current price of AVTR is $11.39, it has decreased 3.62% in the last trading day.
What are the primary business themes or industries for Avantor Inc?
Avantor Inc belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Avantor Inc market cap?
Avantor Inc's current market cap is $7.7B
Is Avantor Inc a buy, sell, or hold?
According to wall street analysts, 20 analysts have made analyst ratings for Avantor Inc, including 4 strong buy, 10 buy, 15 hold, 0 sell, and 4 strong sell
